ADAG Adagene Corp: Multiplikator Forward P/S
Adagene develops shielded tumor antibodies using AI, generating royalties from major partners. Management is focused on the clinical validation of the SAFE-body platform's precision. The forward P/S ratio reflects the market valuation dynamics relative to expected sales, where 14.50 serves as the base parameter value. High scientific authority and B2B sector trust provide the company with stability.
Rincian analitis lan laporan data perusahaan adagene.com (ADAG)
- rega saiki lan proyeksi nilai saham:
- data kapitalisasi saham perusahaan:
- statistik nilai buku emiten:
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal Adagene|ADAG - Tanggungan utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Adagene Inc.|ADAG - Utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku ADAG|ADAG - Tanggungan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Adagene|Rasio cepet adagene.com
- rincian asil keuangan lan kelipatan valuasi:
ADAG - Bathi resik|Proyeksi bathi mangsa ngarep Adagene|ADAG - Pangali rega marang bathi|Pangali Forward P/E Adagene Inc.|ADAG - Pangali PEG|Pangali EV/EBITDA ADAG|ADAG - Bathi operasional sadurunge potongan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Adagene|ADAG - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan adagene.com|ADAG - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Adagene
- indikator dodolan lan pendapatan:
Analisis wiwitan perusahaan:ADAG (Adagene Corp)
To assess the credit quality of Adagene (ADAG), the analyst compares the business's market value with projected revenue, utilizing the forward P/S trend as an indicator of market expectations regarding future sales. The stability of this valuation is bolstered by the company's investments in energy-efficient laboratories and sustainable chemical disposal, which mitigate regulatory risks and confirm the asset's fundamental attractiveness within the biotechnology sector.
Analisis pesaing Adagene
Multiplikator Forward P/S ARGX (argenx)|BioNTech Inc. (BNTX) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Abivax Corp - Multiplikator Forward P/S|ADMA - Multiplikator Forward P/S|PTGX: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan IMVT|KNSA (Kiniksa) - Multiplikator Forward P/S|Multiplikator Forward P/S Grifols SA|Multiplikator Forward P/S ADPT|Celldex Corp (CLDX) - Prakiraan rega marang pendapatan|Multiplikator Forward P/S AUPH (Aurinia Pharmaceuticals)|biocryst.com (BCRX) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|VERA - Rasio rega marang prakiraan pendapatan|DNTH (Dianthus Therapeutics Inc) - Kapitalisasi marang prakiraan pendapatan|PHVS: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep AbCellera Corp (ABCL)|TRML (Tourmaline Bio, Inc.) - Multiplikator Forward P/S|Multiplikator Forward P/S precigen.com|Multiplikator Forward P/S PHAR|Nektar Therapeutics Inc - Kapitalisasi marang prakiraan pendapatan|Multiplikator Forward P/S UPB (Upstream Bio Corp)|Multiplikator Forward P/S Zenas Corp ZBIO|Immunome, Inc. - Multiplikator Forward P/S|Prakiraan rega marang pendapatan gossamerbio.com (GOSS)|KalVista Pharmaceuticals, Inc. (KALV) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan SEPN (Septerna, Inc.)|PVLA (Pieris Pharmaceuticals Inc) - Multiplikator Forward P/S|SVRA: Rega forward marang dodolan|Multiplikator Forward P/S RIGL|Multiplikator Forward P/S anaptysbio.com (ANAB)|Rasio rega marang prakiraan pendapatan Astria Therapeutics, Inc. ATXS|Rega forward marang dodolan ENGN|RAPT - Rasio rega marang prakiraan pendapatan|Aerovate Therapeutics Inc (JBIO) - Multiplikator forward rega marang pendapatan|ACRS: Multiplikator Forward P/S|kyvernatx.com (KYTX) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan TLSA|CABA: Rega forward marang dodolan|Multiplikator Forward P/S VTYX|Rasio kapitalisasi marang dodolan sing dikarepake Theratechnologies, Inc|Rasio rega marang prakiraan pendapatan Avalo Therapeutics, Inc AVTX|ELDN - Multiplikator forward rega marang pendapatan|AGEN - Rasio rega marang prakiraan pendapatan|Climb Bio Inc. (CLYM) - Multiplikator forward rega marang pendapatan|ZURA (Zura Bio Limited) - Multiplikator forward rega marang pendapatan|aTyr Pharmaceuticals (ATYR) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan ImageneBio|Kapitalisasi marang prakiraan pendapatan STTK (Shattuck Therapeutics)|Multiplikator Forward P/S EQ|CNTB - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Multiplikator Forward P/S IMUX (Immunic)|Multiplikator Forward P/S Atara Biotherapeutics, Inc. ATRA|InflaRx GmbH - Multiplikator Forward P/S|XFOR (x4pharma.com) - Kapitalisasi marang prakiraan pendapatan|ACET: Multiplikator Forward P/S|Celularity (CELU) - Multiplikator Forward P/S|INMB (INmune Bio Corp) - Multiplikator Forward P/S|BRNS - Prakiraan rega marang pendapatan|Multiplikator Forward P/S KZR|SABS - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Akari Therapeutics Plc AKTX|ENLV: Kapitalisasi marang prakiraan pendapatan|Q32 Bio Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep GeoVax Corp|EDSA: Multiplikator Forward P/S|ibioinc.com (IBIO) - Multiplikator Forward P/S|CARM (Carisma Therapeutics Inc) - Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan XTLB (XTL Biopharmaceuticals Ltd)|Multiplikator Forward P/S BOLT|Multiplikator Forward P/S hcwbiologics.com (HCWB)|Multiplikator Forward P/S APVO (Aptevo Therapeutics Inc.)|Prakiraan rega marang pendapatan AIM ImmunoTech, Inc.|ADTX - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan GRI|XRTX: Multiplikator Forward P/S|Vyome Therapeutics - Rega forward marang dodolan|REVB (Revelation Biosciences) - Multiplikator Forward P/S|Multiplikator Forward P/S indaptusrx.com|Rasio rega marang prakiraan pendapatan Scinai Immunotherapeutics Ltd. (SCNI)|CALI (calcimedica.com) - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Affimed N.V. AFMD|ALLK - Multiplikator forward rega marang pendapatan|HOOKIPA - Multiplikator Forward P/S|IGMS - Multiplikator Forward P/S|ITOS (iTeos Therapeutics, Inc.) - Multiplikator forward rega marang pendapatan|Ocean Biomedical Inc - Rega forward marang dodolan|TCBP (TC BioPharm (Holdings) PLC) - Multiplikator Forward P/S|Third Harmonic Bio Inc (THRD) - Rasio kapitalisasi marang dodolan sing dikarepake
